DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...

The top 5 most-read chronic obstructive pulmonary disease (COPD) articles of 2024 covered topics such as inhaled medication risks, gabapentinoid use, and the link between high white blood cell ...

while another thousand were given the most common globally used inhaler. A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung ...

Boehringer Ingelheim is the latest company in respiratory health to announce a collaboration to create a 'smart' version of an inhaler ... (COPD) patients. Poor adherence to treatment is a ...

The most common cause of COPD is tobacco smoke ... There is not a one size fits all inhaler approach for COPD. Two types of inhalers COPD patients might use: Tan says some people may just use ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...